Guanqiao Li1,2, Shiping Yang3, Jia Yao2, Zhenping Wang4, Guangyu Yao1, Mingfeng Liu1, Changsheng Ye5. 1. Breast Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China. 2. Department of Breast Surgery, Hainan Province People's Hospital, Haikou, Hainan, 570311, People's Republic of China. 3. Department of Radiation Oncology, Hainan Province People's Hospital, Haikou, Hainan, People's Republic of China. 4. Department of Radiology, Hainan Province People's Hospital, Haikou, Hainan, 570311, People's Republic of China. 5. Breast Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China. yechsh@smu.edu.cn.
Abstract
BACKGROUND: It is controversial for prognosis of invasive micropapillary carcinoma (IMPC) compared with invasive ductal carcinoma (IDC) of the breast. To better understand the difference between IMPC and IDC prognoses, we conducted this retrospective study. METHODS: Data from 33 patients with IMPC were retrospectively reviewed, and the clinicopathologic characteristics and survival status were compared with those of 347 patients with IDC who were treated during the same period. RESULTS: The IMPC cases were of larger tumor size, greater proportion of nodal involvement, and an increased incidence of lymphovascular invasion compared with IDC cases. The overall survival (OS), local relapse-free survival (LRFS), distant metastasis-free survival (DMFS), and failure-free survival (FFS) rates were not significantly different between IMPC and IDC. The 3-year OS rate was 97 vs 94.2 % for the IMPC and IDC patients, respectively. The 3-year FFS rate was 87.9 vs 86.2 % for the IMPC and IDC patients, respectively. For IMPC patients, the 3-year LRFS rate was 93.9 % and in IDC patients was 89.0 %. The 3-year DMFS rates of IMPC patients was 90.9 % and IDC patients was 89 %. CONCLUSIONS: IMPC had poor clinical characteristics, but it showed no difference in OS, FFS, LRFS, and DMFS compare with IDC.
BACKGROUND: It is controversial for prognosis of invasive micropapillary carcinoma (IMPC) compared with invasive ductal carcinoma (IDC) of the breast. To better understand the difference between IMPC and IDC prognoses, we conducted this retrospective study. METHODS: Data from 33 patients with IMPC were retrospectively reviewed, and the clinicopathologic characteristics and survival status were compared with those of 347 patients with IDC who were treated during the same period. RESULTS: The IMPC cases were of larger tumor size, greater proportion of nodal involvement, and an increased incidence of lymphovascular invasion compared with IDC cases. The overall survival (OS), local relapse-free survival (LRFS), distant metastasis-free survival (DMFS), and failure-free survival (FFS) rates were not significantly different between IMPC and IDC. The 3-year OS rate was 97 vs 94.2 % for the IMPC and IDCpatients, respectively. The 3-year FFS rate was 87.9 vs 86.2 % for the IMPC and IDCpatients, respectively. For IMPC patients, the 3-year LRFS rate was 93.9 % and in IDCpatients was 89.0 %. The 3-year DMFS rates of IMPC patients was 90.9 % and IDCpatients was 89 %. CONCLUSIONS: IMPC had poor clinical characteristics, but it showed no difference in OS, FFS, LRFS, and DMFS compare with IDC.
Authors: Albert C Chen; Arnold C Paulino; Mary R Schwartz; Angel A Rodriguez; Barbara L Bass; Jenny C Chang; Bin S Teh Journal: Clin Breast Cancer Date: 2013-04 Impact factor: 3.225
Authors: Hasan Gokce; Merih Guray Durak; Mehmet Mustafa Akin; Tulay Canda; Pinar Balci; Hulya Ellidokuz; Binnaz Demirkan; Ilknur Bilkay Gorken; Ali Ibrahim Sevinc; Mehmet Ali Kocdor; Serdar Saydam; Omer Harmancioglu Journal: Breast J Date: 2013-05-29 Impact factor: 2.431
Authors: Lindsey J Graham; Matthew P Shupe; Erika J Schneble; Frederick L Flynt; Michael N Clemenshaw; Aaron D Kirkpatrick; Chris Gallagher; Aviram Nissan; Leonard Henry; Alexander Stojadinovic; George E Peoples; Nathan M Shumway Journal: J Cancer Date: 2014-01-05 Impact factor: 4.207
Authors: Georgios-Ioannis Verras; Levan Tchabashvili; Francesk Mulita; Ioanna Maria Grypari; Sofia Sourouni; Evangelia Panagodimou; Maria-Ioanna Argentou Journal: Breast Cancer (Dove Med Press) Date: 2022-03-12
Authors: Thaynan Cunha Vieira; Evelyn Ane Oliveira; Bárbara Jaime Dos Santos; Fernanda Rezende Souza; Emerson Soares Veloso; Cristiana Buzelin Nunes; Helen Lima Del Puerto; Geovanni Dantas Cassali Journal: Front Vet Sci Date: 2022-09-12